Cite
HARVARD Citation
Matsuzaki, J. et al. (2019). A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells. Journal for immunotherapy of cancer. 7 (1), p. . [Online].